Pro Medicus, Ltd. · ASX:PME
Pro Medicus — Shareholder Meeting (November 2014)
45 slides from Pro Medicus's shareholder meeting presentation, Nov 21, 2014
Slide 1: FY-14 in Review
For personal use only FY-14 in Review
Slide 2: Chairman's Address 2014
FY-14 in Review For personal use only Chairman's Address 2014
Slide 3: Chairman's Address to AGM: Welcome and Introduction
PRO MEDICUS LIMITED Chairman’s Address to AGM 21 November 2014 WELCOME AND INTRODUCTION For personal use only Ladies and Gentlemen, On behalf of my fellow Directors I would like to welcome you to the Annual General Meeting of Pro Medicus Limited and thank you for taking the time to be with us. My na
Slide 4: Chairman's Report: Overview
CHAIRMAN’S REPORT Overview As foreshadowed at the last Annual General Meeting the Board devoted a significant amount of time to reviewing the company’s strategy and its business model. The For personal use only review was necessary in order to recognize increasing global opportunities and the moveme
Slide 5: Chairman's Report: Visage RIS and Share Price
Management is still pursuing a number of additional significant opportunities, which if consummated will further add to the Company’s growing footprint in this, the world's largest market. The company’s new Visage RIS (previously known as Coral) has continued to be installed at a number of new clien
Slide 6: Closing
Closing In closing, on your behalf, I would like to thank all of our dedicated staff in Australia, North America and Europe for their contribution to the company during what has been a much more positive year. I would also like to thank my fellow directors who have also worked tirelessly and diligen
Slide 7: CEO Address 2014
FY-14 in Review For personal use only CEO Address 2014
Slide 8: FY-14 in Review
FY-14 in Review For personal use only • Revenue increase 27.9% • Profit turnaround - $2.23M • Company debt free • Cash reserves ~ $15M (as of 30/6/14) • Total dividend 2c Share FF • Strongest balance sheet in company’s history
Slide 9: FY-14 in Review
FY-14 in Review For personal use only • Won contract with major US health system – largest in company history • Future contracted revenue $30M plus and growing • Increase foothold in US market • Visage RIS – regaining market share
Slide 10: Pro Medicus listed company
Pro Medicus (ASX:PME) listed company For personal use only Visage Imaging – wholly owned subsidiary Offices in three continents Over 70 staff – 40 Software Engineers EU Headquarters / R&D Berlin, Germany US Headquarters San Diego, CA Group Headquarters Melbourne
Slide 11: Pro Medicus Visage OEM Product Suite
For personal use only PME Ltd Pro Medicus Visage 7 OEM (RIS) Product Suite Visage RIS Pro Medicus.net
Slide 12: Visage RIS – New Technology Platform
Visage RIS – New Technology Platform For personal use only • Thin client App - like Visage PACS • Large Enterprise scalability • Ultimate flexibility with workflow and rules based engines • Cloud deployable
Slide 13: Visage RIS – New UI
Visage RIS – New UI For personal use only • Commercially released and implemented • Speed of product development has increased • Technology is leading edge • Feedback from customers positive • New clients - in combination with Visage • Will reposition company as leader in field • 12 month sales cycl
Slide 14: Visage RIS – New Technology Platform
Visage RIS – New Technology Platform For personal use only • Speed of product development increasing • Technology is leading edge • Feedback from customers positive • Large scale rollouts implemented
Slide 15: Visage RIS – New Technology Platform
Visage RIS – New Technology Platform For personal use only • All customers to transition within 12 to 18 months • New clients purchasing both Visage RIS & PACS • Repositioning company as leader in field • Overseas opportunities
Slide 16: visageimaging.com
For personal use only visageimaging.com
Slide 17: In the beginning…
In the beginning… For personal use only Data sizes 10 Meg to 150Meg
Slide 18: Then there was the web…
Then there was the web… For personal use only Data sizes 30 Meg to 350Meg
Slide 19: Current Imaging Technology
Current Imaging Technology For personal use only • Massive Data explosion • Higher image density - CT leaps from 64 Slices to 256 and now 640 • 3T MRI – over 4 times the dataset of 1.5T • Functional Imaging eg PET scan often > 1.5 to 2 Gig Gigabytes • Digital Breast Tomosynthesis (DBT) files can be
Slide 20: It's better on the server-side…
It’s better on the server-side… For personal use only
Slide 21: What's the Word? – Deconstructed PACS
What’s the Word? - “Deconstructed” PACS, For personal use only VNA use surging – VNA's projected to store 31% of new imaging studies worldwide by 2016 InMedica, May 2012 Of late, imaging IT has been a "barren" field of technology innovation Reiner & McKinley, JDI, June 2012 No single vendor will do
Slide 22: What's the Word? – Deconstructed PACS - VNA
What’s the Word? - “Deconstructed” PACS - VNA For personal use only Radiology Urology Gastroenterology Oncology Cardiology Neurology
Slide 23: What's the Word? – Enterprise Wide Viewer
What’s the Word? - “Enterprise Wide Viewer” For personal use only VNA use surging – VNA's projected to store 31% of new imaging studies worldwide by 2016 InMedica, May 2012 Of late, imaging IT has been a "barren" field of technology innovation Reiner & McKinley, JDI, June 2012 No single vendor will
Slide 24: Introducing Visage
For personal use only Introducing Visage 7
Slide 25: Deconstructed PACS Architecture
“Deconstructed PACS” Architecture For personal use only
Slide 26: Visage 7.0 Technology
Visage 7.0 Technology For personal use only • Visage 7.0 – unique thin client technology. • Extremely well positioned in growing US market.. • Solution addresses > 95% of market • Enterprise Diagnostic Viewer • Referrer (Clinical) distribution • Teleradiology/Remote reading. • Full Enterprise 3D PAC
Slide 27: Visage EASE Mobile
Visage “EASE” Mobile For personal use only • Incredibly fast mobile access • Leading edge functionality • Uses existing Visage infrastructure • Extremely scalable • Significant differentiator to referrer community • New - Visage Ease Pro (Diagnostic) Visage EASE – 1Phone/iPad App
Slide 28: Opportunities - North America
Opportunities - North America For personal use only • Worlds largest market • PACS market estimated at > US $1.5B pa and growing • Paradigm shift to “Deconstructed PACS” – best in breed approach • Market fragmented - in process of consolidating • Visage - recognised leader in Enterprise viewing & 3D
Slide 29: North America
North America For personal use only • Two company transforming deals in the last seven months • Growing pipeline. • Opportunities spread across key market segments: – Enterprise Hospitals – Imaging Centres – Teleradiology/Remote reading groups • Industry consolidation to create further opportunities
Slide 30: WellSpan Health – November 2014
WellSpan Health – November 2014 For personal use only • $8M - 7 year deal • Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) • Operational (transaction based) model • Validation deconstructed model rapidly gaining momentum • Comes on top of other recent US
Slide 31: Large US Health System – April 2014
Large US Health System – April 20144 For personal use only • $20M minimum over 6 years • Visage 7.0 to be used for all diagnostic interpretation and clinical (referrer distribution) • Operational (transaction based) model • Significant upside as Visage technology is rolled out • Implementation 12 to
Slide 32: For personal use only
VISN 23 American Samoa - &— = pro¢medicus OUR SUPPORT. YOUR SUCCESS. prosmedicus
Slide 33: North America – vRad
For personal use only North America – vRad
Slide 34: Operational (Transaction) Model
Operational (Transaction) Model For personal use only • Alternative to capital model • Favoured in recent US contracts • Starting to be adopted in Australia • Applicable to both Visage RIS & Visage PACS • Model based on guaranteed minimums • Upside as client examination volumes grow • Revenue spread
Slide 35: RSNA 2013
For personal use only RSNA 2013
Slide 36: RSNA 2014 – Bigger and better
RSNA 2014 – Bigger and better For personal use only • 100th anniversary of world largest radiology conference • Visage increased presence • 60% larger stand • More staff • More demonstration stations • Major source of future prospects
Slide 37: RSNA 2014
For personal use only RSNA 2014
Slide 38: Australian – Management
Australian – Management For personal use only • Danny Tauber – General Manger Australia • Previously Chief Operations Manager • Has been with the company over 20 years. • Positive impact on customer services • Supervising team for Coral roll out in Australia
Slide 39: US – Management
US – Management For personal use only • Brad Levin – General Manger & Global Head of Marketing • Joined August 2011 • Industry veteran with excellent track record. • Will lead team at RSNA conference
Slide 40: European – Management – Malte Westerhoff
European – Management – Malte Westerhoff For personal use only • Co Founder and co-developer of Visage platform • General Manger of European Operations • Leads team of 38 people • Globally in charge of Visage 7.0 & Visage RIS
Slide 41: New Global Management structure
New Global Management structure For personal use only • To be implemented over next few months • Will overlay current regional structure • Key roles: • Chief technology Officer - CTO • Global Head of Service • Global Head of Sales • Global Head of Marketing • Roles to be filled by current management
Slide 42: Into the Future
Into the Future For personal use only • Continue investment in product R & D • Increase our investment in US • Ramp up implementation and delivery capability to meet demand • Leverage our two leading edge technologies • Maximise reference opportunities from growing client user base
Slide 43: Into the Future
Into the Future For personal use only • Market trends – greater opportunities in North America • Increase presence in Enterprise Hospital space • Visage RIS - ramping up • Operational model - increase recurring revenue base • New global management structure
Slide 44: Summary
Summary For personal use only • FY14 – $2.3M profit turnaround • FY15 – Continued profit growth • Two large US Health systems to come on-stream • Future contracted revenue increased to $35M plus • Company actively pursuing further opportunities
Slide 45: AGM November 2014
prosmedicus OUR SUPPORT. YOUR SUCCESS. AGM November 2014 prosmedicus prosmedicus